The University of Saskatchewan’s vaccine specialists will try to tackle the Zika virus through new research involving testing vaccines on pregnant pigs who have the Zika virus.
The Vaccine and Infectious Disease Organization – International Vaccine Centre, otherwise known as VIDO InterVac will receive $700-thousand for the 3 year project, with funding from Innovation Saskatchewan, Genome Prairie, the Public Health Agency of Canada and VIDO-Intervac.
Volker Gerdts with VIDO-Intervac says there is currently no vaccine or therapy available to combat the infection.
Zika virus has been in the news in the last year, linked to incomplete brain development and small heads in babies born to infected mothers. It is primarily spread by mosquitoes and can also be sexually transmitted.